Find Articles



Return to:Biotechnology Articles
Or:Recent Biotechnology Articles

Study Shows: New Blood Test Proven Six Times More Effective For ...


http://www.forbes.com/prnewswire/feeds/prnewswire/2008/02...

Forbes - Cellestis is a listed Australian biotechnology company commercializing QuantiFERON(R) technology for diagnosing TB and other diseases worldwide. The Company operates through subsidiaries in the USA, Europe and Australia. For more information, visit ...



Article Finder:

February 15, 2008 12:58:00 AM
Article Directory